Gastric microbiota is altered in oesophagitis and Barrett's oesophagus and further modified by proton pump inhibitors

Gastro‐oesophageal reflux can cause inflammation, metaplasia, dysplasia and cancer of the oesophagus. Despite the increased use of proton pump inhibitors (PPIs) to treat reflux, the incidence of oesophageal adenocarcinoma has increased rapidly in Europe and in the United States in the last 25 years....

Ausführliche Beschreibung